Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value: $603M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | PORTOLA PHARMACEUTICALS INC | 900,000 | $50.55M | 8.4% | $36.11 | — | COM | 737010108 |
| TBPH | THERAVANCE BIOPHARMA INC | 950,000 | $37.85M | 6.3% | $23.62 | +62.8% | COM | G8807B106 |
| — | BLUEBIRD BIO INC | 275,000 | $28.89M | 4.8% | $105.05 | — | COM | 09609G100 |
| — | QUOTIENT LTD | 3,549,000 | $26.12M | 4.3% | $10.34 | — | SHS | G73268107 |
| OMER | OMEROS CORP | 1,300,000 | $25.88M | 4.3% | $16.05 | +8.7% | COM | 682143102 |
| GLPG | GALAPAGOS NV | 300,000 | $22.92M | 3.8% | $54.92 | — | SPON ADR | 36315X101 |
| — | JUNO THERAPEUTICS INC | 750,000 | $22.42M | 3.7% | $23.22 | — | COM | 48205A109 |
| — | NEVRO CORP | 270,000 | $20.1M | 3.3% | $57.41 | — | COM | 64157F103 |
| ACRS | ACLARIS THERAPEUTICS INC | 720,000 | $19.53M | 3.2% | $19.94 | +36.4% | COM | 00461U105 |
| ANAB | ANAPTYSBIO | 799,469 | $19.13M | 3.2% | $23.32 | +7.8% | COM | 032724106 |
| — | BLUEPRINT MEDICINES CORP | 367,900 | $18.64M | 3.1% | $27.50 | — | COM | 09627Y109 |
| — | PROTEOSTASIS THERAPEUTICS IN | 3,804,027 | $17.8M | 3.0% | $12.20 | — | COM | 74373B109 |
| — | CLEARSIDE BIOMEDICAL INC | 1,940,880 | $17.68M | 2.9% | $7.30 | — | COM | 185063104 |
| — | MINERVA NEUROSCIENCES INC | 1,997,412 | $17.68M | 2.9% | $7.26 | — | COM | 603380106 |
| EGRX | EAGLE PHARMACEUTICALS INC | 200,000 | $15.78M | 2.6% | $40.56 | +101.6% | COM | 269796108 |
| — | IGNYTA INC | 1,500,000 | $15.53M | 2.6% | $10.35 | — | COM | 451731103 |
| — | MYOKARDIA INC | 1,000,000 | $13.1M | 2.2% | $15.55 | — | COM | 62857M105 |
| — | GEMPHIRE THERAPEUTICS INC | 952,798 | $12.28M | 2.0% | $10.90 | — | COM | 36870A108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 250,000 | $11.5M | 1.9% | $15.30 | +217.1% | COM | 64125C109 |
| — | ALDER BIOPHARMACEUTICALS INC | 900,000 | $10.3M | 1.7% | $32.02 | — | COM | 014339105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 125,000 | $9.97M | 1.7% | $63.91 | 0.0% | COM | 02043Q107 |
| CHRS | COHERUS BIOSCIENCES INC | 620,300 | $8.901M | 1.5% | $21.55 | -10.7% | COM | 19249H103 |
| — | G1 THERAPEUTICS INC | 479,986 | $8.371M | 1.4% | $17.44 | — | COM | 3621LQ109 |
| HRTX | HERON THERAPEUTICS INC | 570,000 | $7.894M | 1.3% | $15.72 | -7.9% | COM | 427746102 |
| — | ARRAY BIOPHARMA INC | 900,000 | $7.533M | 1.2% | $6.75 | — | COM | 04269X105 |
| ARDX | ARDELYX INC | 1,422,738 | $7.256M | 1.2% | $15.57 | -45.5% | COM | 039697107 |
| — | AUDENTES THERAPEUTICS, INC | 323,545 | $6.189M | 1.0% | $17.81 | — | COM | 05070R104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 500,000 | $5.655M | 0.9% | $13.67 | -21.8% | COM | 74366E102 |
| — | SYNERGY PHARMACEUTICALS INC | 1,200,000 | $5.34M | 0.9% | $6.09 | — | COM NEW | 871639308 |
| — | CONTRAFECT CORP | 3,550,000 | $5.148M | 0.9% | $2.80 | — | COM | 212326102 |
| DXCM | DEXCOM INC | 70,000 | $5.121M | 0.8% | $7.91 | +133.4% | COM | 252131107 |
| — | INVUITY INC | 700,000 | $5.075M | 0.8% | $13.53 | — | COM NEW | 46187J205 |
| — | JOUNCE THERAPEUTICS INC | 359,738 | $5.047M | 0.8% | $21.99 | — | COM | 481116101 |
| — | DERMIRA INC | 170,000 | $4.954M | 0.8% | $18.24 | — | COM | 24983L104 |
| FLGT | FULGENT GENETICS INC | 750,000 | $4.793M | 0.8% | $9.22 | -12.5% | COM | 359664109 |
| — | SYROS PHARMACEUTICALS INC | 296,296 | $4.767M | 0.8% | $16.09 | — | COM | 87184Q107 |
| — | AGENUS INC | 1,200,000 | $4.692M | 0.8% | $4.53 | — | COM NEW | 00847G705 |
| — | AGILE THERAPEUTICS INC | 1,250,000 | $4.688M | 0.8% | $4.95 | — | COM | 00847L100 |
| — | INTEC PHARMA LTD JERUSALEM | 809,804 | $4.616M | 0.8% | $5.59 | — | SHS | M53644106 |
| — | RIGEL PHARMACEUTICALS INC | 1,539,750 | $4.204M | 0.7% | $2.90 | — | COM NEW | 766559603 |
| — | CURIS INC | 2,000,000 | $3.78M | 0.6% | $2.44 | — | COM | 231269101 |
| WVE | WAVE LIFE SCIENCES LTD | 202,079 | $3.759M | 0.6% | $17.46 | +23.5% | SHS | Y95308105 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 300,000 | $3.753M | 0.6% | $17.28 | -42.8% | COM | 19459J104 |
| CTMX | CYTOMX THERAPEUTICS INC | 230,000 | $3.565M | 0.6% | $15.82 | -4.7% | COM | 23284F105 |
| SGMO | SANGAMO THERAPEUTICS INC | 400,000 | $3.52M | 0.6% | $6.37 | +0.7% | COM | 800677106 |
| SRNE | SORRENTO THERAPEUTICS INC | 1,690,800 | $3.382M | 0.6% | $9.12 | -78.6% | COM NEW | 83587F202 |
| — | IMMUNE DESIGN CORP | 337,000 | $3.286M | 0.5% | $12.79 | — | COM | 45252L103 |
| — | LIPOCINE INC NEW | 741,496 | $2.981M | 0.5% | $6.47 | — | COM | 53630X104 |
| — | ADVANCED ACCELERATOR APPLIC | 75,000 | $2.928M | 0.5% | $26.76 | — | SPONSORED ADS | 00790T100 |
| — | TRILLIUM THERAPEUTICS INC | 600,000 | $2.64M | 0.4% | $4.40 | — | COM NEW | 89620X506 |
| — | ABEONA THERAPEUTICS INC | 400,000 | $2.56M | 0.4% | $4.85 | — | COM | 00289Y107 |
| RGNX | REGENXBIO INC | 120,000 | $2.37M | 0.4% | $25.52 | -24.1% | COM | 75901B107 |
| OVID | OVID THERAPEUTICS INC. | 223,972 | $2.349M | 0.4% | $13.06 | 0.0% | COM | 690469101 |
| — | RECRO PHARMA INC | 333,200 | $2.343M | 0.4% | $7.16 | — | COM | 75629F109 |
| — | PFENEX INC | 574,966 | $2.306M | 0.4% | $16.67 | — | COM | 717071104 |
| — | ACCELERON PHARMA INC | 75,000 | $2.279M | 0.4% | $32.04 | — | COM | 00434H108 |
| — | ZYMEWORKS INC | 232,008 | $1.937M | 0.3% | $8.35 | — | COM | 98985W102 |
| XNCR | XENCOR INC | 75,000 | $1.583M | 0.3% | $24.05 | -6.8% | COM | 98401F105 |
| — | APTOSE BIOSCIENCES INC | 990,579 | $1.218M | 0.2% | $5.91 | — | COM NEW | 03835T200 |
| — | MYOVANT SCIENCES LTD | 100,000 | $1.17M | 0.2% | $12.44 | — | COM | G637AM102 |
| — | PORTOLA PHARMACEUTICALS INC | 1,000 | $1.16M | 0.2% | $1160.00 | — | CALL | 737010908 |
| — | MERSANA THERAPEUTICS INC | 79,798 | $1.115M | 0.2% | $13.97 | — | COM | 59045L106 |
| — | ONCOBIOLOGICS INC | 1,002,516 | $1.013M | 0.2% | $3.28 | — | COM | 68235M105 |
| — | ABBVIE INC | 6,100 | $939K | 0.2% | $153.93 | — | CALL | 00287Y909 |
| — | HTG MOLECULAR DIAGNOSTICS IN | 203,464 | $541K | 0.1% | $11.05 | — | COM | 40434H104 |
| — | NEOS THERAPEUTICS INC | 50,613 | $369K | 0.1% | $20.88 | — | COM | 64052L106 |
| — | THRESHOLD PHARMACEUTICAL INC | 900,000 | $354K | 0.1% | $0.48 | — | COM NEW | 885807206 |
| — | CELLECTAR BIOSCIENCES INC | 53,649 | $87,000 | 0.0% | $3.40 | — | COM | 15117F302 |
| — | ONCOBIOLOGICS INC | 416,666 | $72,000 | 0.0% | $0.46 | — | *W EXP 02/18/201 | 68235M113 |
| — | ONCOBIOLOGICS INC | 416,666 | $39,000 | 0.0% | $0.45 | — | *W EXP 05/18/201 | 68235M121 |
| — | CELLECTAR BIOSCIENCES INC | 52,999 | $12,000 | 0.0% | $0.55 | — | *W EXP 08/20/201 | 15117F120 |